Site icon Forbidden Knowledge TV

Sasha Latypova and Katherine Watt on the Fraudulent FDA Approval of C-19 Shots

Alexandra Bruce

Sasha Latypova and Katherine Watt have put together a timeline of FDA meetings showing that the FDA issued their approval based on data that was collected for non-investigational use of non-experimental product (EUA countermeasure).

###

by Sasha Latypova

I wrote about this topic here, and we are continuing to compile the research on this issue. As we knew before, the “clinical trials” were a sham and the BLA approval from the FDA is also a sham. We have been able to piece together a more solid evidence from changes to pharmaceutical and other relevant law, and put together a timeline that demonstrates that Poison-19 is a “non-investigational, unapproved” product, aka an illicit drug, poison or weapon trafficked across state lines and internationally by the DOD lead government-pharma cartel.

Pharma companies started on a presumably proper BLA pathway by opening Investigational New Drug applications (exemption for investigational clinical trial use of experimental biologics) in April 2020, then, by October 2020 they switched to the EUA Countermeasures pathway. The EUA pathway is “non investigational”, i.e. no clinical trials are possible for it in compliance with FDA regulations of clinical research.

Brook Jackson observed and documented fraud in Pfizer trials because all of it was fraud. The FDA, pharmas and DOJ were all in on it and DOJ declined to prosecute, then Judge Truncale dismissed the case finding that knowledge of fraud, while not disputed, was immaterial to the FDA decision to approve. That’s correct. Fraud was the essential part of this campaign to intentionally deploy this poisonous, cell transfecting, immune system destroying substance on millions of people – getting “access” to millions of subjects in an illegal medical experiment without consent. The criminals behind this – USG/DOD/FDA/Pharmas knew they will kill and injure millions of people world wide and did not care at all. They planned and prepared for it.

More detailed summaries of this will be coming shortly.

###

by Katherine Watt

Citation key:

US Code, Title 21, Food and Drugs, Chapter 9, Federal Food Drug and Cosmetics Act (FDCA).

Notes include title/topic and year passed by US Congress,1 signed by US Presidents. Most provisions have been amended many times since 1997 when the foundation was laid.

FDA Legal Preparedness Slide Decks (partial list)

Related Bailiwick reporting and analysis:

Exit mobile version